OVIDNasdaq United States
Market cap
$490.863 M
$2.63 -0.76%
Close of 7 Aug 2026
Revenue
$7.25M
#3235 by revenue
Earnings
-$17.4M
Loss-making
Shares outstanding
131,874,634
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ovid Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.